Anti‐adipogenic action of pitavastatin occurs through the coordinate regulation of PPARγ and Pref‐1 expression
暂无分享,去创建一个
A. Gotto | A. Gotto | Jihong Han | J. Han | A. C. Nicholson | D. Hajjar | X. Zhou | W. He | Xiaoye Zhou | J. Han | A. M. Gotto | W. He
[1] H. Green,et al. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line , 1979, Journal of cellular physiology.
[2] O. Rosen,et al. Organelle relationships in cultured 3T3-L1 preadipocytes , 1980, The Journal of cell biology.
[3] D. Bernlohr,et al. Evidence for an increase in transcription of specific mRNAs during differentiation of 3T3-L1 preadipocytes. , 1985, Journal of Biological Chemistry.
[4] H. Green,et al. The nucleotide sequence of three genes participating in the adipose differentiation of 3T3 cells. , 1986, The Journal of biological chemistry.
[5] J. Flier,et al. Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.
[6] M. Lane,et al. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. , 1992, Genes & development.
[7] M. Rao,et al. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. , 1993, The Journal of biological chemistry.
[8] H. Sul,et al. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.
[9] B. Spiegelman,et al. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. , 1993, The Journal of biological chemistry.
[10] S. Freytag,et al. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. , 1994, Genes & development.
[11] O. MacDougald,et al. Regulation of adipocyte development. , 1994, Annual review of nutrition.
[12] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[13] S. McKnight,et al. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. , 1995, Genes & development.
[14] J. Lehmann,et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.
[15] H. Nakata,et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell p4fferentiation in cultured adipogenic cells (3T3-L1). , 1996, European journal of pharmacology.
[16] M. Lazar,et al. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription , 1997, Molecular and Cellular Biology.
[17] J. Gimble,et al. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.
[18] J. Northrop,et al. TNFα-Mediated Inhibition and Reversal of Adipocyte Differentiation Is Accompanied by Suppressed Expression of PPARγ without Effects on Pref-1 Expression. , 1997, Endocrinology.
[19] Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. , 1997, Molecular and cellular biology.
[20] M. Lazar,et al. Peroxisome Proliferator Activated Receptor γ, CCAAT/ Enhancer-binding Protein α, and Cell Cycle Status Regulate the Commitment to Adipocyte Differentiation* , 1997, The Journal of Biological Chemistry.
[21] S. Mandrup,et al. Regulating Adipogenesis* , 1997, The Journal of Biological Chemistry.
[22] B. Spiegelman. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.
[23] H. Sul,et al. Understanding adipocyte differentiation. , 1998, Physiological reviews.
[24] M. Moreno-Aliaga,et al. Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells. , 1999, Molecular pharmacology.
[25] H. Sul,et al. Transcriptional Repression of pref-1 by Glucocorticoids Promotes 3T3-L1 Adipocyte Differentiation* , 1999, The Journal of Biological Chemistry.
[26] X. Xia,et al. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. , 1999, Journal of cellular physiology.
[27] M. Lane,et al. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. , 1999, Biochemical and biophysical research communications.
[28] B. Spiegelman,et al. A Synthetic Antagonist for the Peroxisome Proliferator-activated Receptor γ Inhibits Adipocyte Differentiation* , 2000, The Journal of Biological Chemistry.
[29] S. Kurebayashi,et al. TNF-α Inhibits 3T3-L1 Adipocyte Differentiation without Downregulating the Expression of C/EBPβ and δ , 2001 .
[30] J. Larosa,et al. Pleiotropic effects of statins and their clinical significance. , 2001, American Journal of Cardiology.
[31] J. Liao,et al. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[32] H. Linhart,et al. C/EBPα is required for differentiation of white, but not brown, adipose tissue , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Sul,et al. Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing. , 2002, The Biochemical journal.
[34] H. Sul,et al. Mice Lacking Paternally Expressed Pref-1/Dlk1 Display Growth Retardation and Accelerated Adiposity , 2002, Molecular and Cellular Biology.
[35] M. Kasuga,et al. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. , 2002, Diabetes.
[36] Chunli Song,et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. , 2003, Biochemical and biophysical research communications.
[37] A. Gotto,et al. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line Published, JLR Papers in Press, July 16, 2003. DOI 10.1194/jlr.M300084-JLR200 , 2003, Journal of Lipid Research.
[38] Gwo‐Jaw Wang,et al. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. , 2003, Bone.
[39] H. Sul,et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). , 2003, The Journal of clinical investigation.
[40] Maia M. Jack,et al. Adiponectin gene activation by thiazolidinediones requires PPARγ2, but not C/EBPα—evidence for differential regulation of the aP2 and adiponectin genes , 2003 .
[41] A. Gotto,et al. Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104) , 2004, Circulation.
[42] M. Nakata,et al. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control , 2006, Diabetologia.
[43] S. Farmer. Transcriptional control of adipocyte formation. , 2006, Cell metabolism.
[44] O. MacDougald,et al. Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.
[45] H. Sul,et al. Pref-1 (Preadipocyte Factor 1) Activates the MEK/Extracellular Signal-Regulated Kinase Pathway To Inhibit Adipocyte Differentiation , 2006, Molecular and Cellular Biology.
[46] H. Sul,et al. Preadipocyte factor-1 (Pref-1) Activates MEK/ ERK Pathway To Inhibit Adipocyte , 2007 .